Contenido principal del artículo
Detalles del artículo
National Cancer Institute. Surveillance, epidemiology, and end results program (SEER). 2017. Available at: www.seer.cancer.gov. (Last accessed in August 2020).
Faria CC, Peixoto MS, Carvalho DP, Fortunato RS. The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis. Oxid Med Cell Longev. 2019;2019:2514312.
Kitahara CM, K Rmendiné Farkas D, Jørgensen JOL, Cronin-Fenton D, Sørensen HT. Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2018;103:2216-24.
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J Clin Oncol. 2016;34:4270-6.
Rakhlin L, Fish S. Pregnancy as a risk factor for thyroid cancer progression. Curr Opin Endocrinol Diabetes Obes. 2018;25:326-9.
Spiegel E, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Pregnancy outcomes after thyroid cancer. J Perinat Med. 2019;47:710-6.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315-89.
Yu SS, Bischoff LA. Thyroid Cancer in Pregnancy. Semin Reprod Med. 2016;34:351-5.
Angell TE, Alexander EK. Thyroid Nodules and Thyroid Cancer in the Pregnant Woman. Endocrinol Metab Clin North Am. 2019;48:557-67.
Shim MH, Mok CW, Chang KH, et al. Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci. 2016;59:1–8.
Liang L, Zheng XC, Hu MJ, Zhang Q, Wang SY, Huang F. Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies. J Endocrinol Invest. 2019;42:673-85.
Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 2012;7:e29177.
Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit. 2015;21:283-91.
Fussey JM, Beaumont RN, Wood AR, Vaidya B, Smith J, Tyrrell J. Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study. J Clin Endocrinol Metab. 2020;105:e2398-e2407.
Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77-89.
Park S, Willingham MC, Qi J, Cheng SY. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer. Endocr Relat Cancer. 2018;25:865-77.
Tcheandjieu C, Cordina-Duverger E, Mulot C, et al. Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia. PLoS One. 2020;15:e0228187.
Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, et al. Aging-related disease risks among young thyroid cancer survivors. Cancer Epidemiol Biomarkers Prev. 2017;26:1695–704.
Schonfeld SJ, Ron E, Kitahara CM, et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol. 2011;35:e85-e90.
Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:1751-9.
Xhaard C, Rubino C, Cléro E, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol. 2014;180:1007-17.
Wang P, Lv L, Qi F, Qiu F. Increased risk of papillary thyroid cancer related to hormonal factors in women. Tumour Biol. 2015;36:5127-32.
Caini S, Gibelli B, Palli D, Saieva C, Ruscica M, Gandini S. Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. Cancer Causes Control. 2015;26:511-8.
Cao Y, Wang Z, Gu J, et al. Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015;2015:103515.
Kurata A. Differentiated thyroid cancer: Why does it affect predominantly women during the reproductive period and have higher incidence of mutual association with breast cancer?. Med Hypotheses. 2019;122:5-7.
Fitzpatrick DL, Russell MA. Diagnosis and management of thyroid disease in pregnancy. Obstet Gynecol Clin North Am. 2010;37:173-93.
Yalamanchi S, Cooper DS. Thyroid disorders in pregnancy. Curr Opin Obstet Gynecol. 2015;27:406-15.
Galofré JC, Riesco-Eizaguirre G, Alvarez-Escolá C; Grupo de Trabajo de Cáncer de Tiroides de la Sociedad Española de Endocrinología y Nutrición. Clinical guidelines for management of thyroid nodule and cancer during pregnancy. Endocrinol Nutr. 2014;61:130-8.
Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14:587-95.
Pusztaszeri M, Rossi ED, Auger M, et al. The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel. Acta Cytol. 2016;60:399-405.
Hatch M, Brenner AV, Cahoon EK, et al. Thyroid Cancer and Benign Nodules After Exposure In Utero to Fallout From Chernobyl. J Clin Endocrinol Metab. 2019;104:41-8.
Calina D, Docea AO, Golokhvast KS, Sifakis S, Tsatsakis A, Makrigiannakis A. Management of Endocrinopathies in Pregnancy: A Review of Current Evidence. Int J Environ Res Public Health. 2019;16:781.
Haymart MR, Pearce EN. How Much Should Thyroid Cancer Impact Plans for Pregnancy?. Thyroid. 2017;27:312-4.
Vannucchi G, Perrino M, Rossi S, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 2010;162:145-51.
Messuti I, Corvisieri S, Bardesono F, et al. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol. 2014;170:659-66.
Boucek J, de Haan J, Halaska MJ, et al. Maternal and obstetrical outcome in 35 cases of well-differentiated thyroid carcinoma during pregnancy. Laryngoscope. 2018;128:1493-500.
Chen AC, Livhits MJ, Du L, et al. Recent Pregnancy Is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer. Thyroid. 2018;28:68-71.
Oh HS, Kim WG, Park S, et al. Serial Neck Ultrasonographic Evaluation of Changes in Papillary Thyroid Carcinoma During Pregnancy. Thyroid. 2017;27:773-7.
Muzza M, Degl'Innocenti D, Colombo C, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72:702-8.
Cirello V, Fugazzola L. Positive effect of fetal cell microchimerism on tumor presentation and outcome in papillary thyroid cancer. Chimerism. 2014;5:106-8.
Cirello V, Colombo C, Perrino M, et al. Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the disease. Int J Cancer. 2015;137:2989-93.
Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid. 2014;24:840-4.
Ito Y, Miyauchi A, Kudo T, et al. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital. Thyroid. 2016;26:156-60.
Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27-34.
Pitoia F, Jerkovich F. Dynamic risk assessment in patients with differentiated thyroid cancer. Endocr Relat Cancer. 2019;26:R553-R566.
Rakhlin L, Fish S, Tuttle RM. Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer. Thyroid. 2017;27:396-401.
Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017;317:1888-903.
Modesti C, Aceto P, Masini L, Lombardi CP, Bellantone R, Sollazzi L. Approach to thyroid carcinoma in pregnancy. Updates Surg. 2017;69:261-5.
Zhang Y, Li Y, Shan Z, et al. Association of Overt and Subclinical Hyperthyroidism During Weeks 4-8 with Adverse Pregnancy Outcomes. J Womens Health (Larchmt). 2019;28:842-8.
Zamperini P, Gibelli B, Gilardi D, Tradati N, Chiesa F. Pregnancy and thyroid cancer: ultrasound study of foetal thyroid. Acta Otorhinolaryngol Ital. 2009;29:339-44.
Blackburn BE, Ganz PA, Rowe K, et al. Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv. 2018;12:702-11.
Sioka C, Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril. 2011;95:1552-59.
Wu JX, Young S, Ro K, et al. Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer. Thyroid. 2015;25:133-8.
Ko KY, Yen RF, Lin CL, Cheng MF, Huang WS, Kao CH. Pregnancy Outcome After I-131 Therapy for Patients With Thyroid Cancer: A Nationwide Population-Based Cohort Study. Medicine (Baltimore). 2016;95:e2685.